48
Modalis Ther
4883.T·TSETokyo JPFounded 201630 employees
Micro CapbiotechPublicRare Disease
Platform: CRISPR-GNDM
Market Cap
$0.03B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (4883.T)
Loading 4883.T stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zanuderotide | 488-6819 | Phase 1 | 2 | USP1 | PTSD | ||
| Ivorasimod | 488-6776 | Phase 3 | 1 | HER2 | SLEFabry |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Modalis Ther trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)